Skip to main content
. 2023 Jun 8;11(6):1077. doi: 10.3390/vaccines11061077

Figure 4.

Figure 4

Comparison of AB titers between individuals infected and not infected after booster. The average AB titer (ng/mL) of subjects who became infected within 8 months after the third dose (COVID-19: C8) compared with that of the subjects who did not contract the virus (non-COVID-19: NC8) for all time points considered in the study. Asterisks indicate significant differences ** = p < 0.05.